John Pullman MD
Critical Care Medicine, Hospital Medicine/Hospitalist, Infectious Disease
Infectious Disease Consultant
Join to view full profile
300 W Mercury StButte, MT 59701
Phone+1 406-723-1300
Fax+1 406-723-1360
Dr. Pullman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1977 - 1980
University of Rochester School of Medicine and DentistryClass of 1977
Certifications & Licensure
MT State Medical License 1982 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSuite, Greenway Health, LLC, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Greenway PrimeSUITE, Greenway Health, LLC, 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Study of Debio 1450 for Bacterial Skin Infections
- SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)
Publications & Presentations
PubMed
- 106 citationsRezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.George R Thompson 3rd, Alex Soriano, Oliver A Cornely, Bart Jan Kullberg, Marin Kollef
Lancet. 2023-01-07 - 495 citationsPhase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.Ann R. Falsey, Magdalena E. Sobieszczyk, Ian Hirsch, Stephanie Sproule, Merlin L. Robb
The New England Journal of Medicine. 2021-09-29 - 10 citationsSelective Brain Hypothermia in Acute Ischemic Stroke: Reperfusion Without Reperfusion Injury.Jae H. Choi, Sven Poli, Michael Chen, Thanh N. Nguyen, Jeffrey L. Saver
Frontiers in Neurology. 2020-11-13
Press Mentions
Four Hundred Miles, Four Times a Year: Montana Patient Travels to Utah for Post-Stroke Treatment at Craig H. Neilsen Rehabilitation HospitalOctober 6th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
